CPTN stock was delisted from NASDAQ on
Jan 6, 2025. You can explore more stocks from
Consumer Cyclical sector on this page.
MBOT Microbot Medical Inc
- Stocks
- Healthcare
- NASDAQ: MBOT
Price (delayed)
$2.56
Market cap
$88.95M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.73
Enterprise value
$85.89M
Microbot Medical Inc. is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot's current proprietary
Highlights
Microbot Medical's EPS has increased by 30% YoY and by 9% QoQ
Microbot Medical's debt has plunged by 52% YoY but it has increased by 18% from the previous quarter
MBOT's quick ratio is up by 32% YoY but it is down by 30% from the previous quarter
The equity has decreased by 22% YoY and by 7% QoQ
MBOT's net income is down by 7% year-on-year and by 2.1% since the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.microbotmedical.com
Peers:
NWBO
Key stats
What are the main financial stats of MBOT
Market
Valuations
Earnings
Shares outstanding
34.74M
Market cap
$88.95M
Enterprise value
$85.89M
Price to earnings (P/E)
N/A
Price to book (P/B)
12.28
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$11.63M
Net income
-$11.44M
EBIT
-$11.44M
EBITDA
-$11.35M
Free cash flow
-$8.85M
Per share
Balance sheet
Liquidity
EPS
-$0.73
EPS diluted
-$0.73
Free cash flow per share
-$0.57
Book value per share
$0.21
Revenue per share
$0
TBVPS
$0.39
Total assets
$6.03M
Total liabilities
$2.5M
Debt
$111,000
Equity
$3.53M
Working capital
$3.36M
Debt to equity
0.03
Current ratio
2.37
Quick ratio
2.24
Net debt/EBITDA
0.27
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-175.8%
Return on equity
-234%
Return on invested capital
-356.7%
Return on capital employed
-320.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MBOT stock price
How has the Microbot Medical stock price performed over time
Intraday
1.99%
1 week
5.79%
1 month
84.17%
1 year
181.16%
YTD
128.57%
QTD
69.54%
Financial performance
How have Microbot Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$11.63M
Net income
-$11.44M
Gross margin
N/A
Net margin
N/A
MBOT's operating income is down by 18% year-on-year and by 13% since the previous quarter
MBOT's net income is down by 7% year-on-year and by 2.1% since the previous quarter
Price vs fundamentals
How does MBOT's price correlate with its fundamentals
Growth
What is Microbot Medical's growth rate over time
Valuation
What is Microbot Medical stock price valuation
P/E
N/A
P/B
12.28
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Microbot Medical's EPS has increased by 30% YoY and by 9% QoQ
The equity has decreased by 22% YoY and by 7% QoQ
Efficiency
How efficient is Microbot Medical business performance
The ROE has contracted by 43% YoY and by 7% from the previous quarter
MBOT's return on assets is down by 40% year-on-year and by 11% since the previous quarter
The company's return on invested capital fell by 31% YoY and by 16% QoQ
Dividends
What is MBOT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MBOT.
Financial health
How did Microbot Medical financials performed over time
The total assets is 141% higher than the total liabilities
MBOT's total liabilities has surged by 79% since the previous quarter but it is down by 35% year-on-year
The current ratio is down by 35% from the previous quarter but it is up by 13% YoY
Microbot Medical's debt is 97% less than its equity
Microbot Medical's debt has plunged by 52% YoY but it has increased by 18% from the previous quarter
Microbot Medical's debt to equity has surged by 50% QoQ but it has decreased by 40% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.